Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects. [electronic resource]
Producer: 20130329Description: 119-30 p. digitalISSN:- 1179-2019
- Androstadienes -- administration & dosage
- Anti-Allergic Agents -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Child
- Child, Preschool
- Conjunctivitis -- chemically induced
- Double-Blind Method
- Drug Eruptions -- etiology
- Eyelids -- drug effects
- Female
- Fever -- chemically induced
- Humans
- Incidence
- Infant
- Infant, Newborn
- Inflammation -- chemically induced
- Intraocular Pressure -- drug effects
- Loteprednol Etabonate
- Male
- Multicenter Studies as Topic
- Ophthalmic Solutions -- adverse effects
- Safety
- Tobramycin -- administration & dosage
- Vision, Ocular -- drug effects
- Visual Acuity -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.